Child Neurology·St. Louis, MO

Washington University/B-JH/SLCH Consortium

Signal lift70%91%+21 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
237–269
p10 – p90
Sample N
164
applicants this cycle
This cycle
no tracked aways yet
Match rate
3.0%
5 of 62 applicants
01Cohort funnelthis cycle
N = 164
Applied
164
100.0%
Invited
62
37.8%
Class size
5
3%
J-1 visaH-1B visaF-1 visaCategoricalResearchAcademic/Clinician Educator
Your fitWashington University/B-JH/SLCH Consortium Program

Create a free profile to see your personalized fit

Get started
Contact
SM
Program Director
Soe Soe Mar, MD
Email director
LN
Program Coordinator
Lori A Nichols, MEd
Email coordinator
Training sites4 hospitals · St Louis
  • 1
    St Louis Children's Hospital
    St Louis, MO
    Primary
  • 2
    Washington University/B-JH/SLCH Consortium
    St Louis, MO
    Sponsor
  • 3
    Barnes-Jewish Hospital
    St Louis, MO
    Participant
  • 4
    Shriners Hospitals for Children (St Louis)
    St Louis, MO
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK237269
180205230255280

Level 2 CE data not available

Interview rates
US MD
77%
US DO
17%
US IMG
12%
Non-US IMG
5%
Applicant origin
In-state
75%
Out-of-state
37%
Interview prepChild Neurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesChild Neurology · 25-26
Save this program

Add Washington University/B-JH/SLCH Consortium to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Child Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.